| Followers | 82 |
| Posts | 21862 |
| Boards Moderated | 2 |
| Alias Born | 04/16/2019 |
Tuesday, July 29, 2025 5:46:22 PM
Just bought at $0.77.....
Recent PFSA News
- Profusa Announces Listing Transfer to The Nasdaq Capital Market • GlobeNewswire Inc. • 05/15/2026 11:30:00 AM
- Profusa Receives Favorable Nasdaq Listing Determination • GlobeNewswire Inc. • 05/08/2026 10:00:00 AM
- Profusa Initiates Board-Led Process to Evaluate Strategic Alternatives and Maximize Shareholder Value • GlobeNewswire Inc. • 05/05/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/05/2026 04:15:23 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/04/2026 03:55:55 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/01/2026 07:28:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 09:30:22 PM
- Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform • GlobeNewswire Inc. • 04/06/2026 10:00:00 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/02/2026 02:10:43 PM
- Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering • GlobeNewswire Inc. • 02/27/2026 02:15:00 PM
- Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance • GlobeNewswire Inc. • 02/19/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/13/2026 01:30:00 PM
- Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies • GlobeNewswire Inc. • 02/12/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 01:00:47 PM
- Profusa Announces 1-for-75 Reverse Stock Split • GlobeNewswire Inc. • 02/05/2026 01:00:00 PM
- Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 01/29/2026 01:00:00 PM
- Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue • GlobeNewswire Inc. • 01/16/2026 12:30:00 PM
- Profusa Adds Leading Greek Vascular Surgeon to Customer Base • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Profusa Bolsters European Commercial Network with New French Distributor, MedSell • GlobeNewswire Inc. • 12/31/2025 12:30:00 PM
- Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 • GlobeNewswire Inc. • 12/30/2025 12:30:00 PM
- Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 • GlobeNewswire Inc. • 12/11/2025 01:30:00 PM
- Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 • GlobeNewswire Inc. • 11/24/2025 01:15:00 PM
- Profusa Announces Third Quarter Business and Financial Highlights • GlobeNewswire Inc. • 11/19/2025 10:44:52 PM
